ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.009,03
0,50%
S&P 500
5.881,63
-0,43%
Dow Jones
42.544,22
-0,07%
Euro vs US Dollar
1,03598
0,08%
Bitcoin
95.611,60
1,29%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Daxor Corporation (DXR) Börsenkurse

Daxor Corporation

Daxor Corporation (DXR)

Dynamic Active Retirement Income ETF
7,69
0,00
(0,00%)
Geschlossen 02 Januar 10:00PM
Verzögert um 15 Minuten
0,00
0,00
(0,00%)
Nach Börsenschluss: -
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
7,69
Gebot
7,19
Fragen
9,32
Volumen
-
0,00 Tagesbereich 0,00
7,19 52-Wochen-Bereich 10,04
Marktkapitalisierung
37,22M
Handelsende
7,69
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
17.632
Ausgegebene Aktien
4.840.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
132,36
Gewinn pro Aktie (EPS)
0,06
Erlöse
163k
Nettogewinn
281k

Über Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and compos... Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Misc Health & Allied Svc,nec
Website
www.daxor.com
Hauptsitz
Oak Ridge, New Jersey, USA
Gegründet
2010
Daxor Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DXR. The last closing price for Daxor was US$7,69. Over the last year, Daxor shares have traded in a share price range of US$ 7,19 to US$ 10,04.

Daxor currently has 4.840.000 shares in issue. The market capitalisation of Daxor is US$37,22 million. Daxor has a price to earnings ratio (PE ratio) of 132.36.

DXR Neueste Nachrichten

Weitere Nachrichten

Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum

Healthcare Providers Embrace Blood Volume Analysis (BVA) in Nephrology and Heart Failure Outpatient Care Oak Ridge, TN, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the...

18 Dezember 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

11 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Dezember 2024
Edgar (US Regulatory)

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

21 November 2024
Edgar (US Regulatory)

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24

Elite Cardiovascular Leaders Unite: Driving Innovation Through Shared Excellence Oak Ridge, TN, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood...

09 Oktober 2024
GlobeNewswire Inc.

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Oak Ridge, TN, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael...

08 Oktober 2024
GlobeNewswire Inc.

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device

Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume...

27 September 2024
GlobeNewswire Inc.

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024

Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual...

19 September 2024
GlobeNewswire Inc.

Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management

Review Published in the Prestigious Journal Cardiorenal Medicine Oak Ridge, TN, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...

12 September 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.070.9186351706047.628.2027.56128347.70961509CS
4-1.51-16.41304347839.29.327.56106688.40607218CS
12-1.56-16.86486486499.25107.56176329.04585795CS
26-1.08-12.3147092368.77107.56107769.01014341CS
52-1.87-19.56066945619.5610.047.1967009.03794488CS
156-3.28-29.899726526910.9714.557.1150959.76124839CS
260-3.28-29.899726526910.9714.557.1150959.76124839CS

DXR - Frequently Asked Questions (FAQ)

What is the current Daxor share price?
The current share price of Daxor is US$ 7,69
How many Daxor shares are in issue?
Daxor has 4.840.000 shares in issue
What is the market cap of Daxor?
The market capitalisation of Daxor is USD 37,22M
What is the 1 year trading range for Daxor share price?
Daxor has traded in the range of US$ 7,19 to US$ 10,04 during the past year
What is the PE ratio of Daxor?
The price to earnings ratio of Daxor is 132,36
What is the cash to sales ratio of Daxor?
The cash to sales ratio of Daxor is 228,19
What is the reporting currency for Daxor?
Daxor reports financial results in USD
What is the latest annual turnover for Daxor?
The latest annual turnover of Daxor is USD 163k
What is the latest annual profit for Daxor?
The latest annual profit of Daxor is USD 281k
What is the registered address of Daxor?
The registered address for Daxor is 107 MECO LANE, OAK RIDGE, NEW JERSEY, 37830
What is the Daxor website address?
The website address for Daxor is www.daxor.com
Which industry sector does Daxor operate in?
Daxor operates in the MISC HEALTH & ALLIED SVC,NEC sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AALAmerican Airlines Group Inc
US$ 17,43
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,0184
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,155
(0,00%)
0
AACGATA Creativity Global
US$ 0,846
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 17,43
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,0184
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,155
(0,00%)
0
AACGATA Creativity Global
US$ 0,846
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 17,43
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,0184
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,155
(0,00%)
0
AACGATA Creativity Global
US$ 0,846
(0,00%)
0

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
DXR
Daxor
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten